Repligen Corp - ESG Rating & Company Profile powered by AI
Detailed ESG assessment of Repligen Corp can be accessed by registering for free. The assessment of Repligen Corp employs data points from across the web as well as from public disclosures by Repligen Corp. The assessment of Repligen Corp is assembled by All Street Sevva using leading artificial intelligence.
Repligen Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.2; made up of an environmental score of 6.0, social score of 7.0 and governance score of 5.7.
6.2
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
427 | Scancell Holdings PLC | 6.3 | High |
427 | Verastem Inc | 6.3 | High |
450 | Repligen Corp | 6.2 | High |
450 | Cannasouth Ltd | 6.2 | High |
450 | CareDx International AB | 6.2 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Repligen Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Repligen Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Repligen Corp report the average age of the workforce?
Sign up for free to unlockDoes Repligen Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Repligen Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Repligen Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Repligen Corp offer flexible work?
Sign up for free to unlockDoes Repligen Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Repligen Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Repligen Corp conduct supply chain audits?
Sign up for free to unlockDoes Repligen Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Repligen Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Repligen Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Repligen Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Repligen Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Repligen Corp disclose water use targets?
Sign up for free to unlockDoes Repligen Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Repligen Corp have a product recall in the last two years?
Sign up for free to unlockDoes Repligen Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Repligen Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Repligen Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Repligen Corp disclose parental leave metrics?
Sign up for free to unlockDoes Repligen Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Repligen Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Repligen Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Repligen Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Repligen Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Repligen Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Repligen Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Repligen Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Repligen Corp disclose its waste policy?
Sign up for free to unlockDoes Repligen Corp report according to TCFD requirements?
Sign up for free to unlockDoes Repligen Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Repligen Corp disclose energy use targets?
Sign up for free to unlockDoes Repligen Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Repligen Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Repligen Corp
These potential risks are based on the size, segment and geographies of the company.
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.